Education
About Us
Working with TipRanks
Follow Us
Sihuan Pharmaceutical Holdings Group (HK:0460)
:0460
0460 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.50 - HK$1.02
Previous CloseN/A
Volume8.01M
Average Volume (3M)16.81M
Market Cap
HK$5.50B
Enterprise ValueHK$1.47B
Total Cash (Recent Filing)¥3.31B
Total Debt (Recent Filing)¥95.00M
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Apr 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 27, 2024Dividend Yield3.56%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding9,329,999,000
10 Day Avg. Volume20,825,000
30 Day Avg. Volume16,812,197
Standard Deviation0.22
R-Squared0.18
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Sihuan Pharmaceutical Holdings Group News
PremiumCompany Announcements
Sihuan Pharmaceutical Issues Profit Warning Amid Market Challenges
PremiumCompany Announcements
Sihuan Pharmaceutical Updates on Xuanzhu Biopharm Share Transfer
PremiumCompany Announcements
Sihuan Pharma to Spin Off Xuanzhu Biopharm
PremiumCompany Announcements
Sihuan Pharma Subsidiaries Partner on Weight Loss DrugPremiumCompany Announcements
Sihuan Pharma to Spin Off Xuanzhu Biopharm
PremiumCompany Announcements
Sihuan Pharmaceutical Announces Share Buyback Plan
PremiumCompany Announcements
Sihuan Pharma Renews Key Contract with Hugel---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.73% Mutual Funds
<0.01% Other Institutional Investors
96.42% Public Companies and
Individual Investors
0460 FAQ
What was Sihuan Pharmaceutical Holdings Group ’s price range in the past 12 months?
Sihuan Pharmaceutical Holdings Group lowest stock price was HK$0.49 and its highest was HK$1.02 in the past 12 months.
What is Sihuan Pharmaceutical Holdings Group ’s market cap?
Sihuan Pharmaceutical Holdings Group ’s market cap is HK$5.50B.
When is Sihuan Pharmaceutical Holdings Group ’s upcoming earnings report date?
Sihuan Pharmaceutical Holdings Group ’s upcoming earnings report date is Apr 01, 2025 which is in 30 days.
How were Sihuan Pharmaceutical Holdings Group ’s earnings last quarter?
Sihuan Pharmaceutical Holdings Group released its earnings results on Aug 30, 2024. The company reported -HK$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.004.
Is Sihuan Pharmaceutical Holdings Group overvalued?
According to Wall Street analysts Sihuan Pharmaceutical Holdings Group ’s price is currently Overvalued.
Does Sihuan Pharmaceutical Holdings Group pay dividends?
Sihuan Pharmaceutical Holdings Group pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 3.56%. See more information on Sihuan Pharmaceutical Holdings Group dividends here
What is Sihuan Pharmaceutical Holdings Group ’s EPS estimate?
Sihuan Pharmaceutical Holdings Group ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sihuan Pharmaceutical Holdings Group have?
Sihuan Pharmaceutical Holdings Group has 9,329,999,000 shares outstanding.
What happened to Sihuan Pharmaceutical Holdings Group ’s price movement after its last earnings report?
Sihuan Pharmaceutical Holdings Group reported an EPS of -HK$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.961%.
Which hedge fund is a major shareholder of Sihuan Pharmaceutical Holdings Group ?
Currently, no hedge funds are holding shares in HK:0460
---
Company Description
Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It focuses on the field of cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
---
Technical Analysis
Sino Biopharmaceutical
―
CSPC Pharmaceutical Group
―
China Medical System Holdings
―
Livzon Pharmaceutical Group
―
China Resources Pharmaceutical Group Ltd.
―
---